Protective Effect of a Novel RIPK1 Inhibitor, Compound 4–155, in Systemic Inflammatory Response Syndrome and Sepsis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Effect of a Novel RIPK1 Inhibitor, Compound 4–155, in Systemic Inflammatory Response Syndrome and Sepsis
Authors
Keywords
-
Journal
INFLAMMATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-05-25
DOI
10.1007/s10753-023-01842-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new perspective on the potential application of RIPK1 in the treatment of sepsis
- (2023) Xuesong Wang et al. Immunotherapy
- Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions
- (2023) Lijuan Xu et al. MEDICINAL RESEARCH REVIEWS
- RIPK1 and RIPK3 form mosaic necrosomes
- (2022) Weiwei Qi et al. NATURE CELL BIOLOGY
- Prognostic Accuracy of qSOFA and SIRS for Mortality in the Emergency Department: A Meta-Analysis and Systematic Review of Prospective Studies
- (2022) Hailin Ruan et al. Emergency Medicine International
- ARG1 as a promising biomarker for sepsis diagnosis and prognosis: evidence from WGCNA and PPI network
- (2022) Jing-Xiang Zhang et al. HEREDITAS
- Advances in RIPK1 kinase inhibitors
- (2022) Lu Chen et al. Frontiers in Pharmacology
- Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity
- (2021) Andrea Iorga et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inzidenz der Sepsis in Deutschland und weltweit
- (2021) C. Fleischmann-Struzek et al. Medizinische Klinik-Intensivmedizin und Notfallmedizin
- Caspase inhibition prolongs inflammation by promoting a signaling complex with activated RIPK1
- (2021) Xinyue Huang et al. JOURNAL OF CELL BIOLOGY
- Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors
- (2021) Chunnian Xia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
- (2021) Gang Xu et al. CELL RESEARCH
- Dying cells fan the flames of inflammation
- (2021) Kim Newton et al. SCIENCE
- Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
- (2021) Jing Zhu et al. Acta Pharmaceutica Sinica B
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
- (2020) Kristina E Rudd et al. LANCET
- Antifungal Susceptibility Testing: Current Approaches
- (2020) Elizabeth L. Berkow et al. CLINICAL MICROBIOLOGY REVIEWS
- Crucial Roles of the RIP Homotypic Interaction Motifs of RIPK3 in RIPK1-Dependent Cell Death and Lymphoproliferative Disease
- (2020) Haiwei Zhang et al. Cell Reports
- RIPK1: A rising star in inflammatory and neoplastic skin diseases
- (2020) Liping Jin et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Sepsis Perspective 2020
- (2020) Edward J Septimus JOURNAL OF INFECTIOUS DISEASES
- Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
- (2020) Lauren Mifflin et al. NATURE REVIEWS DRUG DISCOVERY
- Glucocorticoids in Sepsis: To Be or Not to Be
- (2020) Jolien Vandewalle et al. Frontiers in Immunology
- Kinase inhibition in autoimmunity and inflammation
- (2020) Ali A. Zarrin et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibitors of RIP1 kinase: a patent review (2016–present)
- (2020) Philip A. Harris EXPERT OPINION ON THERAPEUTIC PATENTS
- Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors
- (2020) Yuanyuan Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models
- (2019) Ting Zhou et al. Cell Death & Disease
- Identification of the Raf kinase inhibitor TAK‐632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3
- (2019) Xiaofei Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting RIPK1 for the treatment of human diseases
- (2019) Alexei Degterev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
- (2019) Xixi Zhang et al. Nature Communications
- Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target
- (2019) Jing Chen et al. Cells
- A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
- (2019) Panfeng Tao et al. NATURE
- Diagnosis and management of sepsis
- (2018) Tom Evans CLINICAL MEDICINE
- Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis
- (2018) Yu-Lei Gao et al. MEDIATORS OF INFLAMMATION
- Exotoxins and endotoxins: Inducers of inflammatory cytokines
- (2018) Jean-Marc Cavaillon TOXICON
- Transmembrane allosteric energetics characterization for strong coupling between proton and potassium ion binding in the KcsA channel
- (2017) Yunyao Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Matrine Derivate MASM Prolongs Survival, Attenuates Inflammation, and Reduces Organ Injury in Murine Established Lethal Sepsis
- (2016) Jing Xu et al. JOURNAL OF INFECTIOUS DISEASES
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- RIPK1 and RIPK3: critical regulators of inflammation and cell death
- (2015) Kim Newton TRENDS IN CELL BIOLOGY
- Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
- (2015) Malek Najjar et al. Cell Reports
- Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
- (2013) Agnieszka Kaczmarek et al. IMMUNITY
- Structural Basis of RIP1 Inhibition by Necrostatins
- (2013) Tian Xie et al. STRUCTURE
- Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase
- (2012) A Degterev et al. CELL DEATH AND DIFFERENTIATION
- A novel role for RIP1 kinase in mediating TNFα production
- (2012) D E Christofferson et al. Cell Death & Disease
- Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
- (2012) N Takahashi et al. Cell Death & Disease
- RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
- (2011) Linde Duprez et al. IMMUNITY
- Crosstalk in NF-κB signaling pathways
- (2011) Andrea Oeckinghaus et al. NATURE IMMUNOLOGY
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now